Catalyst Wire Dossier Catalyst Wire Dossier

NOVOTTF-200A

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for NOVOTTF-200A, covering 2023-01-04 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of the NovoTTF-200M and Novo TTF-200A Systems for the Treatment of Refractory Spinal Metastasis [Phase 1]

See pricing